肿瘤里的“兵王”是如何与癌症对抗的? episode artwork

EPISODE · Sep 23, 2025 · 2 MIN

肿瘤里的“兵王”是如何与癌症对抗的?

from 天方烨谈

在肿瘤治疗领域,肿瘤浸润淋巴细胞(TIL)疗法是被很多专家看好的一种颠覆性技术。2024年美国食品药品监督管理局批准上市了全球首款TIL药物,也是全球首个获批用于实体瘤的 T 细胞疗法,标志着实体瘤治疗有了新式“武器”。

NOW PLAYING

肿瘤里的“兵王”是如何与癌症对抗的?

0:00 2:50

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of 天方烨谈?

This episode is 2 minutes long.

When was this 天方烨谈 episode published?

This episode was published on September 23, 2025.

What is this episode about?

在肿瘤治疗领域,肿瘤浸润淋巴细胞(TIL)疗法是被很多专家看好的一种颠覆性技术。2024年美国食品药品监督管理局批准上市了全球首款TIL药物,也是全球首个获批用于实体瘤的 T 细胞疗法,标志着实体瘤治疗有了新式“武器”。

Can I download this 天方烨谈 episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!